Filter & sort
The latest funding rounds from the UK tech ecosystem. Updated 16 October 2026.
Announcements
1,485
Total raised
£42.6B
disclosed amounts
This month
£55.3M
raised so far
The over-subscribed funding round was organised by West Hill Capital to support the deployment of Lilli's machine learning care platform.
"The timing for this new preventative approach to care and integration of our smart technology is crucial in meeting the needs of ageing population, this has only been exacerbated by COVID 19. The role of technology has a vital role to play in the future success of care delivery across the UK and globally."
BGF has led a £10.5m growth equity investment into cybersecurity provider e2e-assure.
"We were looking for an investment partner to help us scale and ran an exhaustive selection process to find the right partner to achieve an outcome that fitted with e2e-assure’s culture and customers. BGF was the right choice at the right time for our business. Their expertise in the field of technology and their connections to international markets such as Australia will be key to unlocking growth. We look forward to working with the team to help shape our go to market strategy and bring e2e-assure’s unique offering to more customers than ever before."
The financing round was led by AXA Venture Partners with participation from Swisscom Ventures, Investiere and VentureFounders.
"This is great news for us as we continue to thrive. This funding round marks the continued recognition of the strength of our team as we are now one of the biggest go-to-market data providers in Europe."
The funding will be directed towards research and development while the company native token integrates with Fireblocks.
"While blockchain has been a revolutionary phenomenon in its own right, a lot of people have been conveniently ignoring the disruptive potential autonomous technologies pose to our industry,"
The seed round was supported by a syndicate of investors including the Development Bank of Wales and the UKI2S Innovate Accelerator to fund platform development and laboratory expansion.
"Our investors recognise the potential of our AI-powered antibody drug discovery platform to provide a breakthrough in the industry. With our technology, it will be possible to develop drugs for difficult targets and ultimately reduce drug discovery timescales from years to weeks. In addition to platform development, the funding will enable us to invest in facilities and recruitment; we are grateful to our investors and Innovate UK for their continued support."
.png)
